ProfileGDS4718 / 225903_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 83% 76% 85% 84% 95% 95% 86% 86% 87% 86% 82% 86% 95% 85% 87% 86% 93% 90% 70% 85% 85% 87% 87% 84% 94% 84% 93% 87% 92% 88% 91% 81% 87% 95% 93% 89% 84% 85% 75% 88% 94% 89% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6579586
GSM549102patient 115, normal, homogenized [OPG study]8.1289283
GSM549104patient 119, normal, homogenized [OPG study]7.5108276
GSM549108patient 138, normal, homogenized [OPG study]8.372985
GSM549119patient 077, normal, homogenized [OPG study]8.2389184
GSM549133patient 032, cancer, homogenized [OPG study]10.384395
GSM549139patient 042, cancer, homogenized [OPG study]10.153995
GSM549099patient 107, normal, homogenized [OPG study]8.5265586
GSM549109patient 139, normal, homogenized [OPG study]8.5928986
GSM549110patient 046, normal, homogenized [OPG study]8.7765587
GSM549114patient 063, normal, homogenized [OPG study]8.7610186
GSM549122patient 082, normal, homogenized [OPG study]8.0794882
GSM549134patient 033, cancer, homogenized [OPG study]8.5818786
GSM549136patient 036, cancer, homogenized [OPG study]10.306195
GSM549140patient 044, cancer, homogenized [OPG study]8.4897385
GSM549111patient 047, normal, homogenized [OPG study]8.7747687
GSM549113patient 057, normal, homogenized [OPG study]8.7843486
GSM549132patient 031, cancer, homogenized [OPG study]9.7358893
GSM549137patient 038, cancer, homogenized [OPG study]9.0939890
GSM549142patient 047, cancer, homogenized [OPG study]6.8285970
GSM549100patient 110, normal, homogenized [OPG study]8.3462285
GSM549107patient 135, normal, homogenized [OPG study]8.5517685
GSM549115patient 068, normal, homogenized [OPG study]8.9372487
GSM549116patient 072, normal, homogenized [OPG study]8.8394987
GSM549120patient 078, normal, homogenized [OPG study]8.3936484
GSM549131patient 030, cancer, homogenized [OPG study]9.9021994
GSM549118patient 074, normal, homogenized [OPG study]8.3075384
GSM549129patient 027, cancer, homogenized [OPG study]9.6263593
GSM549123patient 088, normal, homogenized [OPG study]8.7596687
GSM549124patient 006, cancer, homogenized [OPG study]9.364492
GSM549126patient 015, cancer, homogenized [OPG study]8.8549188
GSM549128patient 025, cancer, homogenized [OPG study]9.2811591
GSM549103patient 117, normal, homogenized [OPG study]7.7993381
GSM549117patient 073, normal, homogenized [OPG study]8.9056187
GSM549138patient 041, cancer, homogenized [OPG study]10.238695
GSM549141patient 045, cancer, homogenized [OPG study]9.7904693
GSM549130patient 028, cancer, homogenized [OPG study]8.9451889
GSM549101patient 111, normal, homogenized [OPG study]8.2642584
GSM549105patient 128, normal, homogenized [OPG study]8.402285
GSM549106patient 134, normal, homogenized [OPG study]7.4716275
GSM549112patient 048, normal, homogenized [OPG study]8.950188
GSM549125patient 011, cancer, homogenized [OPG study]9.9000694
GSM549127patient 024, cancer, homogenized [OPG study]8.9462189
GSM549135patient 035, cancer, homogenized [OPG study]9.5194891